NYtor, partner in smart molecular diagnostic assay development!
NYtor designs and develops smart molecular detection assays for a broad range of applications, in collaboration with different partners. Our strength lies in the development of qPCR and point-of-care assays with main focus on the detection of pathogens and their antibiotic resistance and on early cancer screening.
|
|
|
|
|
1-10 employees
View all NYtor employees
|
|
|
Biotechnology Research
|
|
|
Berg en Dalseweg 199, Nijmegen, NL
|
|
|
2007
|
|
|
Point-Of-Care, Contract-Development, Molecular Beacons, Multiplex Assay Design, Quantitative Pcr (Qpcr), Antibiotic Resistance
|
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.